Tapia, Milagritos D <br/><br/>
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.  [electronic resource] 

 -  The Lancet. Infectious diseases  Jan 2016 
 - 31-42 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(15)00362-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antigens, Viral--immunology<br/>Dose-Response Relationship, Immunologic<br/>Double-Blind Method<br/>Ebola Vaccines--administration & dosage<br/>Female<br/>Glycoproteins--immunology<br/>Hemorrhagic Fever, Ebola--immunology<br/>Humans<br/>Immunization, Secondary<br/>Male<br/>Mali<br/>Middle Aged<br/>Single-Blind Method<br/>United States<br/>Young Adult